We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPAY
326
DELISTED
Bottomline Technologies Inc
EPAY
$5.79M 0.04%
+102,580
New +$4.8M
RRD
327
DELISTED
RR Donnelley & Sons Co.
RRD
$5.79M 0.04%
+514,221
New +$4.46M
GM icon
328
General Motors
GM
$80.9B
$5.78M 0.04%
98,616
-5,999
-6% -$350K
DBX icon
329
Dropbox
DBX
$7.78B
$5.75M 0.04%
234,184
-7,010
-3% -$189K
SHW icon
330
Sherwin-Williams
SHW
$84.8B
$5.74M 0.04%
16,310
-71,002
-81% -$22.9M
COP icon
331
ConocoPhillips
COP
$144B
$5.7M 0.04%
79,016
-17,841
-18% -$1.3M
KIDS icon
332
OrthoPediatrics
KIDS
$513M
$5.65M 0.04%
94,352
+5,856
+7% +$365K
KPTI icon
333
Karyopharm Therapeutics
KPTI
$155M
$5.64M 0.04%
58,511
+10,666
+22% +$1.06M
TWST icon
334
Twist Bioscience
TWST
$5.32B
$5.64M 0.04%
72,841
– –
M icon
335
Macy's
M
$6.51B
$5.63M 0.04%
215,064
-12,444
-5% -$339K
CDW icon
336
CDW
CDW
$18.9B
$5.62M 0.04%
27,454
+1,364
+5% +$259K
ODFL icon
337
Old Dominion Freight Line
ODFL
$46.3B
$5.62M 0.04%
31,374
-4,076
-11% -$687K
HSY icon
338
Hershey
HSY
$37.3B
$5.62M 0.04%
29,054
-1,289
-4% -$233K
MLM icon
339
Martin Marietta Materials
MLM
$34.2B
$5.61M 0.04%
12,724
– –
R icon
340
Ryder
R
$9.9B
$5.59M 0.04%
+67,854
New +$5.69M
EXC icon
341
Exelon
EXC
$48.1B
$5.54M 0.04%
134,485
-30,658
-19% -$1.15M
DELL icon
342
Dell
DELL
$239B
$5.5M 0.04%
97,864
-21,542
-18% -$1.2M
GMAB icon
343
Genmab
GMAB
$17.5B
$5.48M 0.04%
138,488
+2,040
+1% +$85.1K
CSX icon
344
CSX Corp
CSX
$94B
$5.47M 0.03%
145,417
-104,256
-42% -$3.68M
OM icon
345
Outset Medical
OM
$86.4M
$5.46M 0.03%
7,904
– –
XENT
346
DELISTED
Intersect ENT, Inc
XENT
$5.46M 0.03%
+199,744
New +$5.41M
TNDM icon
347
Tandem Diabetes Care
TNDM
$1.27B
$5.37M 0.03%
35,688
+101
+0.3% +$13.6K
BC icon
348
Brunswick
BC
$5.23B
$5.37M 0.03%
44,142
+11,902
+37% +$1.16M
ABNB icon
349
Airbnb
ABNB
$90.8B
$5.36M 0.03%
32,194
-1,024
-3% -$180K
PLNT icon
350
Planet Fitness
PLNT
$4.45B
$5.36M 0.03%
59,115
-18,205
-24% -$1.55M
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.